Skip to content

Rigel Pharmaceuticals RIGL Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$597K-1.2%$601K-0.5%$603K-1.3%$607K-1.0%$604K+51.0%
$3.46M+4.0%$2.75M+31.7%$3.36M+27.2%$3.28M+29.6%$3.32M-35.3%
$2.73M+405%$21.98M+51.6%$24.03M+10.8%$30.54M+10,012%-$893K+82.2%
$1.25M0.0%$1.25M0.0%$1.25M0.0%$1.25M0.0%
-$7.98M+24.4%-$25.36M-$33.18M-973%-$23.28M-313%-$10.55M-3,471%
$3.74M$0
$7.5M$0
-$10.92M-2,356%$4.27M+143%$418K+156%$484K+119%
-$16.17M-47.5%-$7.95M-257%-$4.87M-131%-$10.96M-52.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Rigel Pharmaceuticals generate?
Rigel Pharmaceuticals (RIGL) generated $79.3M in operating cash flow over the trailing twelve months.
Where does Rigel Pharmaceuticals's cash flow data come from?
Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.